148
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: CAUSATION AND PREVENTION

Risk Estimation for a Malignant Transformation of Oral Lesions by S100A7 and Doc-1 Gene Expression

, , , , , & show all
Pages 478-484 | Published online: 08 Jul 2011

REFERENCES

  • Silverman S, Jr. Oral Cancer, 4th edition. Hamilton, BC: Decker, 1998; 25–33.
  • Chambers MS, Jacob RF. How carcinogens cause cancer. Tex Dent J 1994;111:13–19.
  • Wenghoefer M, Pesch B, Harth V, Broede P, Fronhoffs S, Landt O, Brüning T, Abel J, Bolt HM, Herberhold C, Vetter H, Ko YD. Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol 2003;77(1):37–41.
  • Pindborg JJ. Oral Cancer and Precancer. Bristol: John Wright and Sons, 1980.
  • Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, Wong DT. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38(3):235–243.
  • Bouquot JE. Epidemiology. In Pathology of the Head and Neck, DG Gnepp (eds.). New York, NY: Churchill Livingstone, 1987, 263–314.
  • Bouquot JE. Reviewing oral leukoplakia-clinical concepts for the 1990s. J Amer Dent Assoc 1991;122:80–82.
  • Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé S, Jepsen S, Winter J. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008a;37(7):660–663.
  • SEER. Surveillance, Epidemiology, and End Results-Brochure. (Program of the National Cancer Institute, United States of America, www.cancer.gov, 2005.
  • Axell, T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odont Revy 1976;27(suppl. 26):1–103.
  • Bouquot JE, Gundlach KKH. Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg Oral Med Oral Pathol 1986;62:284–291.
  • Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36(10):575–580.
  • Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995;6(2):147–160.
  • Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich RH, Martini M, Bergé S, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110(3):351–356.
  • Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Bergé S, Deschner J, Jepsen S, Wenghoefer M. High α-defensin and S100A7 expression and missing DOC-1 downregulation characterize irritation fibromas of the oral cavity and might counteract malignant transformation. J Craniofac Surg 2011;22(1):100–104.
  • Dayan D, Bodner L, Hammel I, Wolman M. Histochemical characterization of collagen fibers in fibrous overgrowth (irritation fibroma) of the oral mucosa: effect of age and duration of lesion. Arch Gerontol Geriatr 1994;18(1):53–57.
  • Kim ST, Kim HJ, Park IS, Park SW, Kim WH, Kim YM. Chronic, reactive conditions of the oral cavity simulating mucosal carcinomas: CT and MR imaging findings with pathologic correlation in five patients. Clin Imaging 2005;29(6):406–411.
  • Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, McBride. p12DOC-1, a growth suppressor, associates with DNA polymerase a/primase. FASEB J 2000;14:1318–1324.
  • Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, Tsuji T. p12DOC-1 is a novel CDK2-associated protein. Mol Cell *** Biol 2001a;20:6300–6307.
  • Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 1995;9:1362–1370.
  • Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene doc-1. J Biol Chem 1998;273:6704–6709.
  • Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, Kohno Y, Ohyama H, McBride J, Kent R, Todd R, Tsuji T, Wong DT. Reduction of p12DOC-1 expression is a negative prognostic indicator in head and neck/oral cancer. Clin Cancer Res 2001b;7:2776–2782.
  • Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calciumdependent and -independent interactions of the S100 protein family. Biochem J 2006;396:201–214.
  • Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 2005;280:29186–29193.
  • Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998;30:567–571.
  • Emberley ED, Murphy LC, Watson PH. S100A7 and the progression of breast cancer. Breast Cancer Res 2004;6:153–159.
  • Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci 2002;7: d1356–1368.
  • Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540–551.
  • Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637–668.
  • Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, S100 proteins in the epidermis. J Invest Dermatol 2004;123:23–33.
  • Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K. Molecular cloning, occurrence, and expression of a novel partially secreted protein ‘‘psoriasin’’, that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991;97:701–712.
  • Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003;51:675–685.
  • El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002;62:6823–6826.
  • Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, (2008) Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 63:352–359.
  • Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007;133: 253–261.
  • Ji J, Zhao L, Wang X, Zhou C, Ding F. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004;130:480–486.
  • Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996;155:2105–2112.
  • Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999;155:2057–2066.
  • Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 2010;5(8):e11939.
  • Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002–2007.
  • Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2008.
  • Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009;27(5):575–581.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.